Current and Future Directions in Metastatic Pancreatic Cancer

OncLive, IPSEN
8/25/20, 10:00 PM
America/New York GMT -4 summer

Description

Evidence-based best practices will help ensure the best possible treatment is selected for a patient. What are the latest options? How are advances today impacting the decisions a physician must make of tomorrow?

 

Join us to learn more about how the field is evolving and hear direct from leading expert, Thomas A. Abrams, MD from Dana-Farber Cancer Institute.

 

Course Objectives:

 

-Review approved therapies and the current treatment landscape in metastic pancreatic cancer

-Discuss novel treatment and potential new targets in metastatic disease

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Review approved therapies and the current treatment landscape in metastic pancreatic cancer, Discuss novel treatment and potential new targets in metastatic disease

Inglês

 

Speakers

Thomas A. Abrams

 

Link to the Event

Banner to the Event

Current and Future Directions in Metastatic Pancreatic Cancer